S1329 Adverse Events Associated With Esophageal Balloon Tamponade Devices: A 15-Year Retrospective Analysis of the FDA MAUDE Database

Introduction: Esophageal balloon tamponade devices are critical interventions for controlling life-threatening variceal bleeding. Despite their therapeutic importance, limited data exists regarding device-related adverse events in post-marketing surveillance. This study analyzes the FDA MAUDE database to characterize adverse events associated with esophageal balloon tamponade devices. Methods: A retrospective analysis of MAUDE database reports from 2010-2025 involving esophageal balloon tamponade devices was conducted. Reports were manually reviewed and categorized into device-related and patient-related adverse events. Duplicate reports were excluded. Event frequencies and percentages were calculated. Results: A total of 40 valid reports were identified involving esophageal balloon tamponade devices. There were 54 device-related events and 52 patient-related events identified. Device-related events were predominantly material integrity issues (18.5%), inflation/deflation problems (16.7%), and deployment/removal difficulties (14.8%). Separation/detachment issues and burst/rupture events each occurred in 6 events (11.1%). Patient-related events included problems with no impact or consequence (73.1%) and unavailable code (11.5%). Serious adverse events included death (3.8%), exsanguination (1.9%), and hemorrhage/bleeding (1.9%). Death was noted in 2 reports with an overall mortality rate of 5.0%. Conclusion: This analysis reveals important safety considerations for esophageal balloon tamponade devices, with device malfunction being predominant (85.0%). Material integrity issues (18.5%) and inflation/deflation problems (16.7%) were the most frequent device problems, highlighting concerns about structural durability and pressure management. Most patient-related events (73.1%) resulted in no clinical impact. However, serious adverse events including death (3.8%) emphasize the critical nature of proper device function in emergency scenarios. These findings highlight the need for improved device reliability and practitioner training.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001132776.30404.2d
Primary Topic
Gastrointestinal Bleeding Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S1329 Adverse Events Associated With Esophageal Balloon Tamponade Devices: A 15-Year Retrospective Analysis of the FDA MAUDE Database

Osama Alshakhatreh, S. Ansari, Mohsin Chundrigar, Khaled Elsokary et al.
The American Journal of Gastroenterology
Gastrointestinal Bleeding Diagnosis and Treatment
article

S1329 Adverse Events Associated With Esophageal Balloon Tamponade Devices: A 15-Year Retrospective Analysis of the FDA MAUDE Database

Osama Alshakhatreh, S. Ansari, Mohsin Chundrigar, Khaled Elsokary, Shahreen Ansari
article en

Abstract

Introduction: Esophageal balloon tamponade devices are critical interventions for controlling life-threatening variceal bleeding. Despite their therapeutic importance, limited data exists regarding device-related adverse events in post-marketing surveillance. This study analyzes the FDA MAUDE database to characterize adverse events associated with esophageal balloon tamponade devices. Methods: A retrospective analysis of MAUDE database reports from 2010-2025 involving esophageal balloon tamponade devices was conducted. Reports were manually reviewed and categorized into device-related and patient-related adverse events. Duplicate reports were excluded. Event frequencies and percentages were calculated. Results: A total of 40 valid reports were identified involving esophageal balloon tamponade devices. There were 54 device-related events and 52 patient-related events identified. Device-related events were predominantly material integrity issues (18.5%), inflation/deflation problems (16.7%), and deployment/removal difficulties (14.8%). Separation/detachment issues and burst/rupture events each occurred in 6 events (11.1%). Patient-related events included problems with no impact or consequence (73.1%) and unavailable code (11.5%). Serious adverse events included death (3.8%), exsanguination (1.9%), and hemorrhage/bleeding (1.9%). Death was noted in 2 reports with an overall mortality rate of 5.0%. Conclusion: This analysis reveals important safety considerations for esophageal balloon tamponade devices, with device malfunction being predominant (85.0%). Material integrity issues (18.5%) and inflation/deflation problems (16.7%) were the most frequent device problems, highlighting concerns about structural durability and pressure management. Most patient-related events (73.1%) resulted in no clinical impact. However, serious adverse events including death (3.8%) emphasize the critical nature of proper device function in emergency scenarios. These findings highlight the need for improved device reliability and practitioner training.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 45%
Gastrointestinal Bleeding Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.